Country: United States
Language: English
Source: NLM (National Library of Medicine)
CALCIUM GLUCONATE MONOHYDRATE (UNII: CZN0MI5R31) (CALCIUM CATION - UNII:2M83C4R6ZB)
WG Critical Care, LLC
INTRAVENOUS
PRESCRIPTION DRUG
Calcium Gluconate in Sodium Chloride Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use The safety of Calcium Gluconate in Sodium Chloride Injection for long term use has not been established. Calcium Gluconate in Sodium Chloride Injection is contraindicated in: •Hyperca lcemia • Neonates (28 days of age or younger) receiving ceftriaxone [see Warnings and Precautions (5.2)] Risk summary Limited available data with Calcium Gluconate Injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. There are risks to the mother and the fetus associated with hypocalcemia in pregnancy [see Clinical Considerations] . The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respecti
Calcium Gluconate in Sodium Chloride Injection is a clear, colorless solution supplied in single-dose bags with an aluminum overwrap available as: Total Strength per Total Volume Strength per mL 24 single-dose bags NDC Bag and Overwrap NDC 1,000 mg per 50 mL 20 mg/mL 44567-620-24* 44567-620-01 1,000 mg per 100 mL 10 mg/mL 44567-622-24 44567-622-01 2,000 mg per 100 mL 20 mg/mL 44567-621-24 44567-621-01 *partial fill container 50 mL volume in a 100 mL container. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Do not freeze. Product should be used within 60 days of removal from aluminum overwrap. Preservative-free. Discard any unused portion in the single-dose bag immediately.
New Drug Application
CALCIUM GLUCONATE IN SODIUM CHLORIDE- CALCIUM GLUCONATE INJECTION, SOLUTION WG CRITICAL CARE, LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION. CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION, FOR INTRAVENOUS USE INITIAL U.S. APPROVAL: 1941 INDICATIONS AND USAGE • Calcium Gluconate in Sodium Chloride Injection is a form of calcium indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. (1) (1) • Limitations of Use: The safety of Calcium Gluconate Injection for long term use has not been established. (1) (1) DOSAGE AND ADMINISTRATION • Administer intravenously (bolus or continuous infusion) via a secure intravenous line (2.1) (2) • See Full Prescribing Information (FPI) for administration rates, and appropriate monitoring (2.1) (2) • Do not dilute Calcium Gluconate in Sodium Chloride Injection prior to use. Any unused portion should be discarded (2.1) (2) • Individualize the dose within the recommended range in adults and pediatric patients depending on the severity of symptoms of hypocalcemia, the serum calcium level, and the acuity of onset of hypocalcemia. See Table 1 in the FPI for dosing recommendations in mg of calcium gluconate for neonates, pediatric and adult patients. (2.2) (2) • Measure serum calcium during intermittent infusions every 4 to 6 hours and during continuous infusion every 1 to 4 hours. (2.3) (2) • Calcium Gluconate Injection is not physically compatible with fluids containing phosphate or bicarbonate. Precipitation may result if mixed. See FPI for all drug incompatibilities. (2.5) (2) DOSAGE FORMS AND STRENGTHS Injection: (3) • Calcium gluconate 1,000 mg per 50 mL (20 mg/mL) single-dose bag (3) (3) • Calcium gluconate 1,000 mg per 100 mL (10 mg/mL) single-dose bag (3) (3) • Calcium gluconate 2,000 mg per 100 m Read the complete document